Lewis H. Titterton Jr. is Director at Anixa Biosciences Inc (ANIX). They have made 65 open-market trades across 4 companies since 2011, most recently 2026-09-23.
CIK 0001499254
64 open-market purchases totalling $4.8M since 2011, against 1 sale. Across 53 scored buys the stock is up 3.3% at ninety days, and 2.6 points ahead of the S&P over the same stretch.
57 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ITUS | 839,544 | $3.9M |
| ANIX | 1,046,003 | $2.8M |
| PRKR | 8,578,170 | $2.2M |
| COPY | 10,335,525 | — |
| Total | $8.9M |
Shares reported on the most recent Form 4, priced at the 2026-09-25 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 61% | 67% | 62% |
| Avg Move | +2.9% | +5.3% | +3.3% |
| Alpha | +4.8% | +4.2% | +2.6% |
| Scored | 57 | 55 | 53 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIX | BUY | 2026-09-23 | 2026-09-25 | $2.69 | $132K | +7.7% | — | — |
| ANIX | BUY | 2026-09-10 | 2026-09-14 | $2.73 | $27K | +1.1% | -2.9% | — |
| ANIX | BUY | 2026-07-20 | 2026-07-20 | $3.47 | $42K | +1.7% | +6.5% | — |
| ANIX | BUY | 2026-07-15 | 2026-07-16 | $3.28 | $9K | +5.7% | +5.1% | -19.8% |
| ANIX | BUY | 2026-06-16 | 2026-06-17 | $2.64 | $7K | +2.3% | +21.3% | -3.6% |
| PRKR | BUY | 2025-11-18 | 2025-11-18 | $0.21 | $2.0M | N/A | N/A | N/A |
| ANIX | BUY | 2025-07-31 | 2025-08-04 | $3.08 | $31K | -9.7% | -9.1% | +25.8% |
| ANIX | BUY | 2025-07-11 | 2025-07-15 | $3.14 | $31K | +0.0% | -7.8% | +40.4% |
| ANIX | BUY | 2025-01-23 | 2025-01-27 | $2.94 | $9K | +13.5% | +8.5% | -0.4% |
| ANIX | BUY | 2025-01-22 | 2025-01-23 | $3.01 | $6K | +1.0% | -2.0% | -7.1% |
| ANIX | BUY | 2025-01-21 | 2025-01-22 | $2.59 | $16K | -5.7% | +3.7% | -8.4% |
| ANIX | BUY | 2025-01-17 | 2025-01-17 | $2.57 | $26K | +13.1% | +16.2% | +4.6% |
| ANIX | BUY | 2024-07-30 | 2024-08-01 | $3.08 | $150K | -6.9% | -2.7% | +8.1% |
| ANIX | BUY | 2024-07-25 | 2024-07-29 | $3.01 | $26K | +3.3% | +9.7% | +32.3% |
| ANIX | BUY | 2024-06-14 | 2024-06-18 | $2.68 | $11K | -9.4% | +18.8% | +34.7% |
| ANIX | BUY | 2024-06-13 | 2024-06-14 | $2.70 | $1K | -10.2% | +21.5% | +25.3% |
| ANIX | BUY | 2024-06-10 | 2024-06-12 | $2.66 | $20K | -7.5% | +3.7% | +16.5% |
| ANIX | BUY | 2024-06-07 | 2024-06-10 | $2.52 | $27K | -7.4% | -13.6% | +16.5% |
| ANIX | BUY | 2024-04-09 | 2024-04-10 | $3.28 | $49K | -6.5% | -6.8% | -31.4% |
| ANIX | BUY | 2022-04-26 | 2022-04-27 | $2.79 | $28K | +14.0% | +19.4% | +18.0% |
| ANIX | BUY | 2022-01-12 | 2022-01-13 | $3.28 | $16K | -13.4% | -15.9% | -23.2% |
| ANIX | BUY | 2022-01-11 | 2022-01-12 | $3.20 | $6K | -8.6% | -7.4% | -22.3% |
| ANIX | BUY | 2022-01-10 | 2022-01-11 | $3.08 | $18K | -11.4% | -9.1% | -23.8% |
| ANIX | BUY | 2022-01-07 | 2022-01-10 | $3.08 | $34K | -1.9% | -2.5% | -17.7% |
| ANIX | BUY | 2021-10-29 | 2021-11-01 | $4.76 | $174K | -9.2% | -33.6% | -36.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.